An estimated 1.1 million people in the U.S. are currently living with HIV.That means the work to remove barriers to health ...

As the first COVID-19 vaccines are rolled out around the world, HIV/AIDS experts and advocates have sought to reassure those ...

Despite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human ...

Gilead has become a significant name in the HIV landscape after its twice-yearly PrEP treatment Yeztugo touted 99.9% efficacy ...

A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...

Review of current evidence indicates immune checkpoint inhibitors offer comparable efficacy and safety for NSCLC in people ...

Primary effectiveness was measured by the number of patients with HIV-1 RNA ≥50 copies/mL at Week 48, as well as the number of patients with a change in CD4 cell count, and the proportion of patients ...

People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer ...

A nationwide campaign in Spain is raising awareness of the labour rights of people living with HIV, while strengthening the commitment of businesses, public administrations and civil society to combat ...

"You know, it's not the best news. But there was other news that could have been a lot worse, you know?" Charlie Sheen said.

ICIs are safe and effective for HIV-positive NSCLC patients, with no significant differences in survival outcomes compared to ...